Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia

Clinical Trial ID NCT01486446

PubWeight™ 1.68‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01486446

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genes and epigenetic processes as prospective pain targets. Genome Med 2013 0.93
2 Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief. Expert Opin Ther Targets 2016 0.84
Next 100